Jan 5, 2015, 10:55 AM by Michael Croft

FierceBiotech | Spark Therapeutics, a company with a strong Phase III drug candidate bidding to be the first gene therapy approved for use in the U.S., has filed for an IPO, planning to sell $86 million in public shares.

Jan 5, 2015, 10:30 AM by Michael Croft

Reuters | In advance of a final decision to be handed down January 7, the FDA today revealed that staff reviewers have recommended approval of a biologic made by Novartis that imitates Amgen's off-patent Neupogen.

Jan 2, 2015, 11:20 AM by Michael Croft

Bio-IT World | Looking to open its highly sensitive Simoa instruments to new customers, Quanterix is opening an accelerator in its Massachusetts lab, where users can test out homebrewed assays in search of new biomarker tests that detect proteins at extremely low concentrations.

Jan 2, 2015, 10:00 AM by Michael Croft

Reuters | 2014 was a banner year for drug approvals, Reuters reports. 41 novel medications were approved, the most since the all-time high of 53 approvals in 1996.

Jan 2, 2015, 00:00 AM by Michael Croft

SAN FRANCISCO, CA - Jan 2, 2015 - GE Healthcare - Strategic SWOT Analysis Review provides a comprehensive insight into the company's history, corporate strategy, business structure and operations

Dec 31, 2014, 10:20 AM by Michael Croft

Bio-IT World | Inside the Box | As petascale supercomputing systems grow more accessible, there is now an opportunity for life sciences researchers to run computations on genomic or molecular data that would be impossible with desktops or small clusters — but only if they are willing to adapt their informatics tools to new computing architectures.

Dec 30, 2014, 12:10 PM by Michael Croft

Bio-IT World | News and product releases from around the industry, including a study of attitudes toward newborn genomic testing, and Definiens' latest tissue quantification software.

Dec 30, 2014, 00:00 AM by Michael Croft

SAN FRANCISCO, CA, UNITED STATES - Dec 30, 2014 - TechNavio's analysts forecast the Global Imaging Biomarkers market to grow at a CAGR of 15.09 percent over the period 2013-2018

Dec 29, 2014, 11:15 AM by Michael Croft

The Scientist | Adam Marcus and Ivan Oransky, the founders of the Retraction Watch blog, offer their annual list of the year's most prominent, spectacular, or telling retractions in the scientific literature.

Dec 24, 2014, 08:00 AM by Michael Croft

More Intelligent Life | One woman's search for family history led her to 23andMe first, and the reindeer next.

Dec 22, 2014, 13:05 PM by Michael Croft

Bio-IT World | Oxford Nanopore has created the world's first functional nanopore sequencer, the pocketsize MinION. As early access users start to share their experiences with the instrument, a picture is emerging of a world where DNA data could be gathered anywhere, anytime — and by almost anyone.

Dec 22, 2014, 00:00 AM by Michael Croft

SAN FRANCISCO, CA, UNITED STATES - Dec 22, 2014 - Synopsis
Canadean's "Biocurv Medical Instruments, Inc.: Consumer Packaged Goods - Company Profile & SWOT Report" contains in depth information and data about the company and its operations

Dec 22, 2014, 00:00 AM by Michael Croft

WIRED | It's been a roller-coaster year for science. It started with what looked like a remarkable breakthrough in stem cell science, which was soon followed by a stunning announcement by cosmologists: the first detection of gravitational waves, direct evidence for a popular theory of how the universe began. But as the year draws to a close, the first of these discoveries has been thoroughly discredited, and the second appears to be on the ropes.

Dec 19, 2014, 17:00 PM by Michael Croft

Bio-IT World | Bina Technologies announced this morning that it has been acquired by Roche. Financial details were not disclosed. The Roche acquisition is, “the best outcome that could have happened for our company,” co-founder and CEO Narges Bani Asadi told Bio-IT World today.

Dec 19, 2014, 09:00 AM by Michael Croft

Bio-IT World | Fitting a two-meter strand of DNA into a nucleus a few microns long is no simple thing. The genome isn’t wadded up and stuffed into every cell in the body, it’s folded meticulously. A five-year effort to look at the genome inside cells suggests that these folds may play crucial roles in function.

Dec 19, 2014, 00:00 AM by Michael Croft

NIH Director's Blog | At the time that we completed a draft of the 3 billion letters of the human genome about a decade ago, it would have cost about $100 million to sequence a second human genome. Today, thanks to advances in DNA sequencing technology, it will soon be possible to sequence your genome or mine for  $1,000…

Dec 19, 2014, 00:00 AM by Michael Croft

CALIFORNIA, CA, UNITED KINGDOM - Dec 19, 2014 - The report firstly introduced   Electroencephalography Monitors  basic information including   Electroencephalography Monitors  definition, classification, application and Market chain overview;   Electroencephalography Monitors  Market policy and plan,   Electroencephalography Monitors  product specification, manufacturing process, cost structure etc

Dec 18, 2014, 08:00 AM by Michael Croft

Dec 18, 2014, 00:00 AM by Michael Croft

MIT Technology Review | Scientists are starting to open their DNA databases online, creating a network that could pave the way for gene analysis at a new scale.

Dec 17, 2014, 09:00 AM by Michael Croft

Boston Globe | Big pharma is expanding its reach in the Boston area, picking up small to mid-sized biotechs for billions of dollars. Last week Merck announced plans to buy Cubist Pharmaceuticals for $9.5 billion.